Rapid preparation of (11C)flumazenil:: Captive solvent synthesis combined with purification by analytical sized columns

被引:17
作者
Cleij, Marcel C.
Clark, John C.
Baron, Jean-Claude
Aigbirhio, Franklin I.
机构
[1] Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge CB2 2QQ, England
[2] Univ Cambridge, Addenbrookes Hosp, Neurol Unit, Cambridge CB2 2QQ, England
关键词
N-methyl-C-11]flumazenil; PET; captive solvent; SEP-PAK; BENZODIAZEPINE;
D O I
10.1002/jlcr.1152
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To produce the radioligand [N-methyl-C-11]flumazenil at very high specific radioactivity for our small animal imaging studies we have developed procedures for its rapid synthesis, purification and analysis. We have developed 'micro-reactor' apparatus which are assembled from analytical HPLC guard columns packed with stainless steel powder for performing the carbon-11 methylation reactions. These highly efficient reaction columns enable high radiochemical yields to be obtained with very small amounts of precursor (20-40 mu g). The very small amount of reactants used enables the use of small analytical-sized HPLC columns for the rapid purification of the radioligand. Combining these techniques has enabled us to consistently prepare [N-methyl-C-11]flumazenil from [C-11]iodomethane With radiochemical yields of 80% (decay corrected). This results in 8-10GBq of [N-methyl-C-11]flumazenil at very high specific radioactivities of 520-600 GBq/mu mol at the end-of-synthesis. The total preparation time from end-of-bombardment of cyclotron-produced [C-11]carbon dioxide to end-of-synthesis is 20 min. A quality control method based on very rapid HPLC analysis (completed within 2 min) on a micro-analytical HPLC column has also being developed to reduce the time from the end-of-synthesis to injection for imaging. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 10 条